Science Explorer Back to mapMap
Discussion
Company · Tarrytown · United States

ARMGO Pharma (United States)

armgo.comROR OpenAlex
Research works
6
▼ 74% vs 2018-21
Citations
230
38.5 per fractional work
Top-10% rate
37.0%
all institutions 10.0%
Open access
40%
world 40%
International
20%
world 18%
ARMGO Pharma (United States)

Not ranked overall: ARMGO Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ARMGO Pharma (United States) work in?

In all years, 52% of research at ARMGO Pharma (United States) is in Life Sciences, 36% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (36%), Computer Science (6%). It does 1.6× the world's share of Life Sciences.

Life Sciences: 3 fractional works · 51.8% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 42.4% of its workMolecular Biology: 2 fractional works · 40.9% of its workGenetics: 0 fractional works · 1.3% of its workImmunology and Microbiology: 0 fractional works · 4.2% of its workImmunology: 0 fractional works · 4.2% of its workNeuroscience: 0 fractional works · 3.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 2.9% of its workBiological Psychiatry: 0 fractional works · 0.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.8% of its workPharmaceutical Science: 0 fractional works · 1.8% of its workHealth Sciences: 2 fractional works · 35.9% of its workMedicine: 2 fractional works · 35.9% of its workEpidemiology: 0 fractional works · 6.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 6.2% of its workPharmacology: 0 fractional works · 4.7% of its workSurgery: 0 fractional works · 4.7% of its workHematology: 0 fractional works · 3.7% of its workRheumatology: 0 fractional works · 2.7% of its workReproductive Medicine: 0 fractional works · 1.8% of its workInfectious Diseases: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.2% of its workFamily Practice: 0 fractional works · 1.0% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 1.0% of its workImmunology and Allergy: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.5% of its workPhysical Sciences: 1 fractional works · 10.1% of its workComputer Science: 0 fractional works · 5.5% of its workComputational Theory and Mathematics: 0 fractional works · 5.5% of its workChemistry: 0 fractional works · 2.9% of its workOrganic Chemistry: 0 fractional works · 2.9% of its workPhysics and Astronomy: 0 fractional works · 1.7% of its workStatistical and Nonlinear Physics: 0 fractional works · 1.7% of its workSocial Sciences: 0 fractional works · 2.2% of its workArts and Humanities: 0 fractional works · 1.7% of its workHistory and Philosophy of Science: 0 fractional works · 1.7% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workALL ITS WORKARMGO Pharma(United States)6fractional works, all years
Life Sciences52%Physical Sciences10%Health Sciences36%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology342.4%
    2. Immunology and Microbiology04.2%
    3. Neuroscience03.4%
    4. Pharmacology, Toxicology and Pharmaceutics01.8%
    1. Medicine235.9%
    1. Computer Science05.5%
    2. Chemistry02.9%
    3. Physics and Astronomy01.7%
    1. Arts and Humanities01.7%
    2. Psychology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from ARMGO Pharma (United States)?

The most cited paper from ARMGO Pharma (United States) is "Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cells" (Ramadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh et al., 2003), with 220 citations. Next come "Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge" (177) and "Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge" (126).

Most cited papers
#PaperReleasedCitations
1 Cotreatment with the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) enhances imatinib-induced apoptosis of Bcr-Abl–positive human acute leukemia cells Ramadevi Nimmanapalli, Lianne Fuino, Corinne Stobaugh et al. · Blood Open access 2 Apr 2003 220
2 Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge Jose M. Galarza, Theresa E. Latham, Albert Cupo · Viral Immunology Jun 2005 177
3 Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus Challenge Jose M. Galarza, Theresa E. Latham, Albert Cupo · Viral Immunology Mar 2005 126
4 Mast Cell Activation Syndrome: A Primer for the Gastroenterologist Leonard B. Weinstock, Laura Pace, Ali Ranjideh Rezaie et al. · Digestive Diseases and Sciences 23 Apr 2020 61
5 Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms Craig D. Shimasaki, Richard E. Frye, Rosario Rich Trifiletti et al. · Journal of Neuroimmunology Open access 14 Dec 2019 60
All 17 most cited papers, with filters and sorting

Which research topics does ARMGO Pharma (United States) publish most on?

By volume in 2022-now: Berberine and alkaloids research, Drug Solubulity and Delivery Systems, Muscle Physiology and Disorders and Advanced Drug Delivery Systems.

Berberine and alkaloids research: 0 fractional worksDrug Solubulity and Delivery Systems: 0 fractional worksMuscle Physiology and Disorders: 0 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksInflammatory Myopathies and Dermatomyositis: 0 fractional worksCardiomyopathy and Myosin Studies: 0 fractional works
PharmacologyPharmaceutical ScienceMolecular BiologyEpidemiology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Berberine and alkaloids research Pharmacology 0 works
  2. 2 Drug Solubulity and Delivery Systems Pharmaceutical Science 0 works
  3. 3 Muscle Physiology and Disorders Molecular Biology 0 works
  4. 4 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  5. 5 Inflammatory Myopathies and Dermatomyositis Epidemiology 0 works
  6. 6 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works
  7. 7 Pancreatic function and diabetes Surgery 0 works
  8. 8 Genetics and Neurodevelopmental Disorders Genetics 0 works
  9. 9 Diabetes and associated disorders Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.2%not open59.8%

World: 40% of research is openly available.

with international co-authors19.6%domestic only80.4%

World: 18% is written across borders.

How has ARMGO Pharma (United States)'s research output changed?

Output in 2022-2025 was 74% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is ARMGO Pharma (United States) as a percentage of every work published that year, 0.0000069% in 2020.

0.000050%0.00010%ARMGO Pharma (United States)0.0000052% in 202420102020

Fractional works of ARMGO Pharma (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tarrytown

All research institutions in Tarrytown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ARMGO Pharma (United States). Posts are plain text and can be reported.